Skip to main content

[IMCAS Asia 2026 Special ㉒ | Interview] "Clinical Evidence Is the Key to a Lasting Competitive Edge" — John Kim, CEO, Bluecore Company

 A competitive gap built on price has to be rebuilt somewhere else the moment a rival matches you on quality. At IMCAS Asia 2026 in Bangkok, we met John Kim, CEO of Bluecore Company, the manufacturer of PICOREMAX, CureMax, and Trinity. Kim believes clinical data is the only thing that can build a sustainable competitive edge over lower-cost Chinese devices, reasoning that clinical data and treatment parameters cannot be easily matched simply by building a comparable device. Bluecore's largest market is Japan; the company is expanding its base across Southeast Asia, including Malaysia and Singapore, while preparing to enter India and the Americas. The day before IMCAS Asia opened, it held its inaugural BLUE ALLIANCE DAY, broadening its engagement with Asian buyers. He pointed to regulatory asymmetry as a key challenge for overseas expansion. Drawing on the company's own experience, he noted that market entry can take more than three years in China and three to four years in Europe following the transition from the MDD to the MDR, while foreign devices enter the Korean market comparatively quickly. What companies need, he said, is not subsidies but a level playing field. 

#MedicalAestheticNews #BluecoreCompany #PICOREMAX #CureMax #Trinity #IMCASAsia2026

★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20126



Labels:

Comments

Post a Comment

Popular posts from this blog

[ASLS KOREA 2026 Spring ②] 'Is It Really Safe?' — In the Skin Booster Market, the First Question Physicians Ask Is Changing

 This is part two of our on-site coverage from the ASLS KOREA 2026 Spring Congress. The skin booster and drug delivery sections drew as much attention as the EBD halls. Active ingredients are diversifying rapidly — PCL, PDLLA, CaHA, HA, human acellular dermal matrix, exosomes, TCA — and so are the approaches, spanning injectable and topical formats, biostimulators and hydration- and regeneration-focused formulations. Yet across every booth, the first response from clinicians converged around a single question: "Is it really safe?" As ingredient options diversify, the demand for rigorous validation of nodule risk and adverse events is rising in parallel — a shift that was unmistakable on the exhibition floor. We visited skin booster and drug delivery company booths to report firsthand.  #MedicalAestheticNews #ASLSKOREA2026 #ASLS #VAIM #HIGHERCorporation #BAZBIOMEDIC #Curiosis #reH #Humedix #WiQo #DNCAesthetics #HuonsMeditech #Dexlevo #PrimorisInternational ★ Article Link: http...
Post a Comment
Read more

[Hands-On] The Power of Quasar Tension from the Scalp! Full-Face ‘SUNNY’ Lifting by Dr. Hyungdon Yoon_Part 1

 Dr. Hyungdon Yoon of Toxnfill Clinic Gangdong Cheonho has released a hands-on demonstration video showcasing his treatment techniques using the Quasar Tip of SUNNY, the premium RF lifting device by SHENB. As the No. 1 user of the Virtue RF tip for two consecutive years (2023 and 2024), Dr. Yoon now highlights the core principles of SUNNY and demonstrates his most effective treatment strategies. According to Dr. Yoon, the Quasar Tip delivers precise targeting and deep thermal energy, working directly on the facial ligaments to regenerate stretched ligaments and create a natural lifting effect. Notably, SUNNY is the first RF device capable of treating the scalp, allowing practitioners to strengthen the scalp ligaments and support the entire face from above — a unique and innovative approach. Dr. Yoon emphasizes that SUNNY improves elasticity without reducing fat, enabling vertical facial shortening and enhanced horizontal lifting without concerns of volume loss. He also highlights t...
Post a Comment
Read more

Less Pain, Longer Results — The Evolution of Skin Booster Injectors, Derma Shine Duo RF

 Dr. Hoyeon Choi of Clim Clinic is actively utilizing a new multi-needle injector that combines radiofrequency (RF) technology with skin booster treatments. According to Dr. Choi, this device adds RF functionality to the conventional multi-needle injector, creating synergistic effects in drug delivery, skin texture improvement, elasticity enhancement, and extended duration of results. He also highlighted reduced drug loss and less pain compared to manual injections as key advantages. Furthermore, he noted that when combined with existing monopolar RF or HIFU devices, the elasticity improvement effects become even more pronounced, making it a highly recommended option especially for international patients who cannot visit frequently. #MedicalAestheticNews #HuonsMeditech #DermaShine_Duo_RF #ClimClinic_Myeongdong #Dr_HoYeon_Choi ★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=10960
Post a Comment
Read more